Pharmosa Biopharm Inc. logo

Pharmosa Biopharm Inc. (6875)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
32. 45
-0.55
-1.6667%
NT$
- Market Cap
- P/E Ratio
1,000% Div Yield
142,813 Volume
- Eps
NT$ 33
Previous Close
Add Transaction
Day Range
31 33
Year Range
31 65
Want to track 6875 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Pharmosa Biopharm Inc. (6875) Statistics

Valuation metrics

Market Cap -
Enterprise value 3.66B
Trailing P/E (ttm) -10.9
Forward P/E -
PEG ratio 0.15
Price/Sales (ttm) 60.98
Price/Book (mrq) 2.87
Enterprise Value/Revenue 52.93
Enterprise Value/EBITDA -9.64

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 93.41K
Average volume (90 days) 134.85K

Price summary

52-Week low 31
52-Week high 65
Beta -
50-Day moving average 35.83
200-Day moving average 38.11

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 511:500
Last split Date 10 Jul 2023

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -5.58%
Operating margin -5.73%

Operational effectiveness

Return on assets -0.24%
Return on equity -0.24%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.53
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.98
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 6.72
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 18.1%
Book value per share (mrq) 11.35

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -